Hester Biosciences

Hester Biosciences EBIT per Employee

The EBIT per Employee of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026 is 978,023.09 INR. In the previous year, EBIT per Employee was 656,637.81 INR — a change of 48.94% (higher).

EBIT per Employee

978,023.09INR

YoY

48.94%

Last updated:

EBIT per Employee of Hester Biosciences is 2026 978,023.09 INR. EBIT per Employee of Hester Biosciences was 2025 656,637.81 INR. It decreases by 48.94% higher compared to the previous year.

The Hester Biosciences EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
903,003.32 INR
Jan 1, 2020
676,176.05 INR
Jan 1, 2021
819,393.94 INR
Jan 1, 2022
1.81 M INR
Jan 1, 2023
447,720.06 INR
Jan 1, 2024
526,363.64 INR
Jan 1, 2025
656,637.81 INR
Jan 1, 2026
978,023.09 INR
The Hester Biosciences EBIT per Employee history
YEAREBIT per EmployeeYoY
978,023.09INR+48.94%
656,637.81INR+24.75%
526,363.64INR+17.57%
447,720.06INR-75.23%
1.81 MINR+120.56%
819,393.94INR+21.18%
676,176.05INR-25.12%
903,003.32INR+58.15%
570,990.85INR+28.53%
444,233.38INR+26.53%
351,101.50INR+43.26%
245,074.73INR+27.25%
192,596.70INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

EBIT per Employee of Hester Biosciences is 978,023.09 INR in 2026.

EBIT per Employee of Hester Biosciences changed from 656,637.81 INR to 978,023.09 INR, representing a 48.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Hester Biosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Hester Biosciences

All Key Metrics — Hester Biosciences